Skip to main content

Side-by-side comparison

CompareDigital DiagnosticsvsEyenuk

Compare tools

2 of 4 tools selected

AI Ophthalmology & Retinal Imaging Software

Digital Diagnostics

Autonomous AI for diabetic retinopathy screening

SF Score
8.2/10
Pricing
Contact sales
AI Ophthalmology & Retinal Imaging Software

Eyenuk

AI retinal screening across multiple eye diseases

SF Score
7.9/10
Pricing
Contact sales
Add third toolCompare up to 4 side by side

Compare features, strengths, trade-offs, and best-fit use cases.

Where each one leads

Read straight from the published figures below — not a ranking, and not a recommendation.

  • Highest SF Score

    Digital Diagnostics8.2/10

    2 of 2 are scored

At a glance

The short version

The facts each tool publishes, lined up so you can scan down a column. Anything the catalog does not establish is marked as such rather than counted against the tool.

Digital Diagnostics

SF Score
8.2 / 10
Category
AI Healthcare & Medical Software › AI Ophthalmology & Retinal Imaging Software

Eyenuk

SF Score
7.9 / 10
Category
AI Healthcare & Medical Software › AI Ophthalmology & Retinal Imaging Software

Key differences

Where these tools actually diverge

The decision dimensions that separate this set, with each tool's own position stated plainly. No winner is declared — fit depends on your workflow.

Positioned for

Digital Diagnostics

AI Ophthalmology & Retinal Imaging Software

Eyenuk

AI Ophthalmology & Retinal Imaging Software

Pricing model

Digital Diagnostics

Contact sales

Eyenuk

Contact sales

SoftFinders Score

Digital Diagnostics

8.2 / 10

Eyenuk

7.9 / 10

Feature comparison

Capability matrix

Grouped by area. Every state carries a word as well as a colour, and anything the catalog has not established stays neutral rather than counting as a missing feature.

1 row differs 6 identical

Capability comparison across the selected tools. Each row is a capability; each column is a tool.
Capability Digital DiagnosticsEyenuk
Overview
SF Score8.2 / 10Value7.9 / 10Value
Pricing modelCustomValueCustomValue
CategoryAI Healthcare & Medical Software › AI Ophthalmology & Retinal Imaging SoftwareValueAI Healthcare & Medical Software › AI Ophthalmology & Retinal Imaging SoftwareValue
Core features
Primary Care UseDesigned for primary care screening settingsYesYes
Care RoutingRoutes positive screens to ophthalmologyYesYes
Patient ReportsGenerates patient-facing screening reportsYesYes
Image QualityChecks captured image quality before analysisYesYes

Scroll the matrix sideways to see every column.

Listed by one tool only

4 capabilities are published by a single tool in this set. That does not mean the others lack them — only that the catalog has not established an answer either way.

Use cases

What each tool is built for

The workflows each tool publishes for itself. Cards appear only for tools that list use cases.

Digital Diagnostics

  • Route positive screens to ophthalmology
  • Support multi-disease retinal screening
  • Standardize diabetic eye screening programs
  • Generate patient-facing screening reports
  • Screen for diabetic retinopathy at scale

+5 more on the Digital Diagnostics profile

Eyenuk

  • Standardize diabetic eye screening programs
  • Generate patient-facing screening reports
  • Screen for diabetic retinopathy at scale
  • Bring eye screening into primary care
  • Route positive screens to ophthalmology

+1 more on the Eyenuk profile

Pros & cons

Strengths and compromises

Each tool's published strengths and the compromises that come with them, as supplied — not scored or ranked against each other. Longer lists fold; nothing is left out.

Digital Diagnostics

Pros

  • Pioneering autonomous diagnostic AI device
  • Established primary care screening footprint
  • Strong regulatory positioning track record

Cons

  • Regulatory scope is condition-specific for now
  • Positive screens still need ophthalmology follow-up
  • Workflow change required at primary care sites

Eyenuk

Pros

  • Multi-disease retinal screening focus in practice today
  • Established eye screening AI brand
  • Active programs across screening sites

Cons

  • Workflow placement remains clinic-specific
  • Positive screens require ophthalmology follow-up
  • Buyer scope is narrower than imaging giants
  • US clearance limited to diabetic retinopathy

Pricing

What each one costs

Published pricing signals only. Where a tool has not established a price, that is what it says — never a zero and never "free".

Next step

Ready to try one?

A matrix narrows the field; a free trial settles it. Open whichever tool fits your workflow best, or start a different comparison.

Compare another set of tools